State Stem Cell Agency ICOC Agenda 5/12/09




California State Stem Cell Agency



MEETING NOTICE AND AGENDA
SPECIAL MEETING OF THE
INDEPENDENT CITIZENS’ OVERSIGHT COMMITTEE (“ICOC”)
TO THE CALIFORNIA INSTITUTE FOR REGENERATIVE MEDICINE

Organized Pursuant To The
CALIFORNIA STEM CELL RESEARCH AND CURES ACT

 

Date: Tuesday, May 12th, 2009

Time:  7:30 to 9:00AM (Estimated)

URL: http://65.197.1.15/att/confcast
Enter Conference ID#: 100945, then click "Go". 

Locations:

  • CIRM
    210 King Street
    San Francisco, CA 94107
  • Sherry Lansing Foundation
    2121 Avenue of the Stars
    Los Angeles, CA 90067
  • UC Davis School of Medicine
    4610 X Street, Suite 3103
    Sacramento, CA 95817
  • Salk Institute
    10010 North Torrey Pines Road
    La Jolla, CA 92037
  • CONNECT
    8950 Villa La Jolla Drive
    Suite A124
    La Jolla, CA 92037
  • ValleyCare Health System
    5575 West Las Positas Blvd.
    Suite 300
    Pleasanton, CA 94588
  • University of California, Berkeley
    200 California Hall
    Berkeley, CA 94720
  • 8170 Laguna Blvd., #101
    Elk Grove, CA 95758
  • 330 Plaza Street
    Healdsburg, CA 95448
  • University of California, Irvine
    160 Aldrich Hall
    Irvine, CA 92697-3175
  • 2476 Lancelot Lane
    Los Angeles, CA 90077
  • 5 Via Delizia
    Hillsborough, CA 94010
  • 2815 Sugarman
    La Jolla, CA 92037
  • 855 Katella St.
    Laguna Beach, CA 92651
  • 136 Roanoke Street
    San Francisco, CA 94131
  • Stanford University
    Clark Center, S363
    318 Campus Drive
    Stanford, CA 94305
  • 226 S. Stanley Dr.
    Beverly Hills, CA 90211
  • UCSF Laurel Heights
    3333 California Street
    Room LH 150
    San Francisco, CA 94118
  • San Francisco City Attorney's Office
    San Francisco International Airport International Terminal, 5th Floor
    San Francisco, CA 94128
  • 11480 North Torrey Pines
    La Jolla, CA 92037
  • UCLA School of Medicine
    Office of the Dean
    10833 Le Conte Avenue
    Los Angeles, CA 90095

 

 

  1. Call to Order 
  2. Roll Call

    [Members of the Public will be invited to provide testimony before or during consideration of each agenda item. Speakers are asked to limit their testimony to three (3) minutes.]

  3. Consideration of CIRM’s response to NIH draft guidelines during 30-day public comment period.

    • CIRM Draft Response to NIH Draft Guidelines — UPDATED FOLLOWING 5/12/09 ICOC TELECONFERENCE

  4. Consideration of CIRM’s statement of principles relating to federal biosimilar legislation (HR 1427 and 1548).
  5. Public comment. The Committee will accept public testimony on any matter under its jurisdiction that is not on the agenda, but the Committee cannot act on any such matter at this meeting.

 

THE ORDER OF BUSINESS MAY BE CHANGED WITHOUT NOTICE.
Notice is hereby given that the order of consideration of matters on this agenda may be changed without prior notice.

**NOTICE**

The California Institute for Regenerative Medicine and its Independent Citizens Oversight Committee, and any subcommittees thereof, comply with the Americans with Disabilities Act (ADA) by ensuring that the meeting facilities are accessible to persons with disabilities, and providing that this notice and information given to the Members of the Committee is available to the public in appropriate alternative formats when requested. If you need further assistance, including disability-related modifications or accommodations, you may contact Melissa King at the California Institute for Regenerative Medicine at 415-396-9100 no later than the day prior to the meeting.

Questions or requests for additional information prior to the Independent Citizens Oversight Committee meeting may be referred to Melissa King at the California Institute for Regenerative Medicine at mking@cirm.ca.gov or 415-396-9100.

This meeting agenda is also available on the website for the California Institute for Regenerative Medicine at http://www.cirm.ca.gov.

Transcript URL: 
Transcript